North Carolina Strategic Prevention Framework for Prescription Drugs (SPF-Rx)

North Carolina Strategic Prevention Framework for Prescription Drugs (SPF-Rx) is sponsored by North Carolina Department of Health and Human Services (NCDHHS) / Division of Mental Health, Developmental Disabilities and Substance Abuse Services (DMHDDSUS). This grant targets the priority issue of prescription drug misuse in North Carolina.

It aims to raise awareness about the dangers of sharing medications and works with pharmaceutical and medical communities on the risks of overprescribing to young adults.

Strategic Prevention Framework for Prescription Drugs Questions Due 04/01/2022 at 5:00pm EDT Applications Due 04/19/2022 at 5:00pm EDT Anticipated Notice of Award Anticipated Performance Period Service Community Based Substance Abuse Prevention Issuing Agency NC Department of Health and Human Services; Division of Mental Health, Developmental Disabilities and Substance Abuse Services (DMHDDSAS) E-mail Applications and Questions to Email RFA.

responses@dhhs. nc.

gov THE UNDERSIGNED HEREBY SUBMITS THE FOLLOWING APPLICATION AND CERTIFIES THAT: (1) he or she is authorized to bind the named Contractor to the terms of this RFA and Application; (2) the Contractor hereby offers and agrees to provide services in the manner and at the costs described in this RFA and Application; (3) this Application shall be valid for 60 days after the end of the application period in which it is submitted.

To Be Completed By Contractor: > Contractor Name: Catchment Area # (see p. 5): > Contractor’s Street Address: E-Mail Address: > City, State & Street Address Zip: Telephone Number: > Name & Title of Authorized Representative: DUNS Number: > Signature of Authorized Representative: Date: Unsigned or Incomplete Applications Shall Be Returned Without Being Reviewed 2 4. 0 Definition, Acronyms and Abbreviations 6 6.

0 Division Responsibilities 9 7. 0 Term of Contract, Options to Extend 9 9. 0 Invoicing and Reimbursement 10 10.

0 The Solicitation Process 10 11. 0 General Information on Submitting Applications 11 12. 0 Application Content and Instructions 13 13.

0 Evaluation Criteria and Scoring 16 Attachment A Statement of Assurance 22 Attachment B SPF-Rx Program Evaluation Requirements 24 Attachment C Community Readiness Assessment 25 Attachment D Organizational Chart 26 Attachment E Project Timeline 27 Attachment F Line-Item Budget 28 Appendix A Certifications 30 3 Through this Request for Applications (RFA), the NC Department of Health and Human Services (NC DHHS);(DMHDDSAS) is launching the NC Strategic Prevention Framework for Prescription Drugs (SPF-Rx) grant funded by the Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Prevention (CSAP).

Through this initiative, the DMHDDSAS seeks to collaborate to use the Strategic Prevention Framework to address target substances of abuse with Local Management Entity-Managed Care Organizations (LME-MCOs), Community-based organizations implementing substance abuse prevention, and Community coalitions working to address substance abuse prevention.

This project will be utilized to address overdose deaths related to prescription drug misuse and abuse within our state.

Areas of focus include raising awareness about the dangers of sharing medications and working with medical communities on the risks of overprescribing to young adults; raising community awareness and bring prescription drug abuse prevention activities and education to schools, communities, parents, prescribers, and their patients.

DMHDDSAS is sponsoring this RFA to address substances of high use and impact using evidence-based prevention policies, programs, and practices. Funded applications must utilize the Strategic Prevention Framework to plan and implement this initiative. Prescription drug use among youth and young adults must be addressed in each funded proposal along with collaborating with the medical community to help raise awareness.

NC DHHS is committed to proactively planning for and addressing substances of concern in communities. This includes legal substances of use for youth and adults that are being misused and overprescribed. In North Carolina, from 2000 to 2019, more than 16,500 North Carolinians died from unintentional opioid-involved overdose deaths.

In 2019 alone, nearly five (5) North Carolinas died each day from unintentional opioid overdose. Opioid-involved overdoses have steadily increased, and while there was a decrease in overdose deaths and emergency department (ED) visits in 2018, these overdoses are on the rise again as of 2020. (NC Opioid Dashboard, 2021).

As of August 2021, there have been 727 opioid overdose ED visits, which includes unintentional overdoses in North Carolina compared to the 803 of August 2020 (https://www. injuryfreenc. ncdhhs.

gov ). Commonly prescribed pain medications (i.e., oxycodone, hydrocodone, codeine) were the leading cause of opioid-involved overdoses. North Carolina males have over twice the unintentional opioid-involved overdose death rate compared to females (21.

2 compared to 9. 8 per 100,000, respectively). Whites have the highest unintentional opioid-involved overdose death rate, at 20.

1 per 100,000, followed closely by American Indians at 19. 3 per 100,000. Unintentional opioid-involved overdose death rates are highest among adults ages 25-54 ( https://www.

injuryfreenc. ncdhhs. gov ).

According to the 2019 Youth Risk Behavior Survey, North Carolina high school students are more likely to take a prescription pain medicine without a doctor's prescription or differently than how a doctor told them to use it (counting drugs such as codeine, Vicodin, Oxycontin, Hydrocodone, and 4 Percocet, one or more times during their life) compared to across the United States (16. 6% compared to 14. 3%).

North Carolina high school females were also more likely to take a prescription pain medicine without a doctor's prescription or differently than how a doctor told them to use it than males (17. 1% to 15. 6%) (YRBS, 2021).

North Carolinians have also been overprescribed and prescribed opioids at a higher dose than what is recommended. The percentage of North Carolina residents being dispensed an opioid pill in 2020 was 13. 7% on an annual basis, which accounts for 1,432,749 residents/patients (NC Opioid Dashboard, 2021).

The number of individuals receiving dispensed opioids has decreased by 36%, but there is still much to be done around education on safer prescribing practices among NC healthcare providers (NC Opioid Action Plan, 2020). This round of SPF-Rx funding will address prescription drug misuse and abuse.

In addition, communities will also focus on working with their local medical communities on the risks of overprescribing to young adults and raising awareness about the dangers of sharing medications.

Applicants are required to : • have a current state-funded contract or an established relationship with one or more LME-MCOs and must include, at minimum, affirmation from the LME-MCO of its agreement and support of the proposal • have a demonstrated presence and operations in North Carolina for a minimum of 1 year prior to proposal submission.

2) Eligibility is open to non-profit entities only Applications MUST include a focus on prescription drug misuse among youth ages 12-17 and adults 18 years and older.

3) Applicants must provide service in one or more of these 10 counties to be eligible to apply: Burke, Caldwell, Cherokee, Clay, Columbus, Mitchell, Richmond, Robeson, Scotland, and Swain 4) Separate applications must be submitted for each identified community in which services are proposed. Failure to meet any of the above eligibility criteria and requirements will cause the application to be deemed ineligible.

The maximum award for this RFA is $32,000 per award per year for up to seven (7) awardees. Annual funding will be available contingent on funding availability, performance, fiscal management, quality management, outcomes and data submission. 5 Applications will be reviewed and ranked according to the evaluation criteria outlined in Section 13.

0. Applicants must submit a budget summarizing the attributed costs for this project and complying with the terms outlined in this RFA. Applicants should complete the Line-Item Budget Template provided in Attachment F.

Proposed budgets cannot exceed $32,000 in total costs in any year of the proposed project for proposals that include alcohol and one additional target substance. As noted in Section 5, applicants are strongly recommended to commit a part-time (0. 5 FTE) position to this project.

3.

1 SOURCE OF FUNDS AND PASS-THROUGH REQUIREMENTS Federal Award Identification Number : H79SP082765 Federal Award Date : September 7, 2021 Subaward Performance Period : May 1, 2022 – September 29, 2022 Amount of Federal Funds Obligated by this action : up to $224,000 Total Amount of Federal Funds Obligated to the Subrecipient : $32,000 per award Total Amount of the Federal Award : $384,000 Federal Award Project Description : Federal Awarding Agency : SAMHSA Pass-through Entity : Non-profit entities CDFA Name : Substance Abuse and Mental Health Services_Projects of Regional and National Significance 3.

2 FEDERAL FUNDING ACCOUNTABILITY AND TRANSPARENCY ACT (FFATA) As a subrecipient of federal funds, each selected grant recipient will be required to provide certain information required by the Federal Funding Accountability and Transparency Act (FFATA), including the organization’s DUNS number. Please see https://fedgov. dnb.

com/webform for free registration. Additional information about FFATA is available at https://www. fsrs.

gov/ . ## 4. 0 DEFINITIONS, ACRONYMS AND ABBREVIATIONS ATOD : Alcohol, Tobacco & Other Drugs CSAP: Center for Substance Abuse Prevention CSRS: Controlled Substance Reporting System DMHDDSAS : Division of Mental Health, Developmental Disabilities and Substance Abuse Services ED : Emergency Department EBPs : Evidence-based Practices/Programs.

FFY : Federal Fiscal Year FTE : Full-time equivalent HIV : Human Immunodeficiency Virus LME-MCO: Local Management Entities – Managed Care Organizations MOU : Memorandum of Understanding NC DHHS : North Carolina Department of Health and Human Services SAMHSA : Substance Abuse and Mental Health Services Administration SPF-Rx : Strategic Prevention Framework for Prescription Drugs STD/STI : Sexually Transmitted Disease/ Sexually Transmitted Infection TA : Technical Assistance YRBS : Youth Risk Behavior Survey Overarching Intent and Expectation Grantees will be expected to: • Develop and demonstrate an understanding of local conditions pertaining to prescription drug misuse and abuse to support the scope of the proposed project application.

7 • Develop and demonstrate the ability to plan and mobilize their community to address local conditions relevant to substances targeted in the proposal.

• Develop a comprehensive action plan with a primary focus on evidence-based environmental management strategies; including but not limited to addressing prescription drug misuse (harm reduction approaches are not permitted under the terms of this funding, (see Eligibility and Requirements).

• Implement a comprehensive environmental management approach which includes evidence-based programs, policies and practices that address prescription drug misuse. • Create a sustainability plan with options for fundraising as necessary. • Participate in technical assistance and training related to the SPF-Rx grant.

• Include related expenses in the project budget (Local or statewide meetings and conferences, all anticipated travel expenses, and other necessary costs related to implementing proposed project activities.) • Designate a part-time (0. 5 FTE) grant coordinator position for this project.

> Utilize data to create and implement a Health Disparities Plan related to the target substances that: 1) identifies service area, sub-populations ( i.e. racial, ethnic, sexual/gender minority groups) vulnerable to disparities and 2) implement strategies targeted to the identified group(s) to decrease disparities in prescription drugs. 5.

1 PROGRAMMATIC REQUIREMENTS AND PRIORITIES As stated in the Purpose, this project will support projects that address the identified target substances and youth and young adults at the community level. All project activities must comply with the design and framework outlined in this RFA. Additionally, the contractor shall adhere to the budget and proposed timeline submitted as part of this application.

5. 2 CONTRACTOR RESPONSIBILITIES A. Have affiliation with a host organization (e.g., an organization with 501(c)(3) or NC non-profit status) and be able to receive federal funds.

B. Must include a focus on raising awareness about the dangers of sharing medications and working with medical communities on the risks of overprescribing to young adults. C.

Must agree to measure and report outcomes, established, and approved by SPF-Rx Evaluators and the DMHDDSAS. Applicants must demonstrate the ability to comply with the SPF-Rx National Cross Site evaluation requirements. D.

Must agree to follow all data rules and regulations when sharing Controlled Substance Reporting System (CSRS) data that’s provided by the NC CSRS Team. E.

Refusal of Funds from Alcohol, Tobacco, Electronic Vapor Product and/or Marijuana and Pharmaceutical Entities - The applicant and/or its affiliate(s) agree that it shall not accept 8 any grant or anything else of value from any alcohol, tobacco, electronic vapor product and/or marijuana manufacturer, distributor, or other alcohol, tobacco, electronic vapor product, marijuana, or pharmaceutical related entity. F.

Harm reduction- The contractor agrees not to use SPF-Rx funds to purchase naloxone 5. 3 PERFORMANCE STANDARDS AND EXPECTATIONS A. Contractor must agree to measure and report outcomes, established, and approved by SPF-Rx Evaluators and the DMHDDSAS.

Applicants must demonstrate the ability to comply with the quarterly or annual SPF-Rx National Cross Site evaluation requirements. 5. 4 REPORTING REQUIREMENTS A.

DMHDDSAS will provide any necessary reporting templates to the Contractor within 30 days of their due date. B. Quarterly Reporting Requirements a.

Contractor shall provide quarterly status reports, using a template provided by DMHDDSAS, which will outline Contractor activity/progress on activities outlined in the project proposal and timeline. b. Elements of the quarterly reports shall include: i.

Names and status of individuals serving as staff. ii. Identification of community partners involved with the project.

iii. Relevant assessment data to support initiatives and progress on completion. iv.

Summary of current challenges and barriers. vi. Anticipated next steps and completion dates.

c. By the fifteenth (15 th ) of each month, the contractor shall submit an invoice for allowable expenditures from the preceding month, and copies of back-up documentation (receipts, travel logs, and timesheets/HR documentation) a. Contractor agrees to comply with any additional reporting requirements required by SAMHSA.

b. DMHDDSAS shall work to ensure any federal reporting requirements introduced does not create duplicative reporting with existing DMHDDSAS reporting forms. a.

Contractor agrees to report on required documents and deliverables. 5. 5 OTHER CONTRACTOR REQUIREMENTS Program staff working under this award agree to work collaboratively and in good faith with DMHDDSAS identified training and technical assistance for this grant.

5. 6 CONTRACTOR QUALIFICATIONS AND CAPACITY Eligible applicants are limited to non-profit providers that have an established relationship with LME-MCOs. Applicants shall: 9 • Have been providing services in North Carolina for one year prior to the submission of this proposal.

• Provide a clear organization/collaboration chart that shows structure and management detail. • Be able to describe the community’s existing resources and any previous or current efforts to address the identified problems discussed in the Assessment section. Include any developing or established efforts in this description.

• Be able to describe the community partners that will participate in this project. Include a description of the partner’s current area(s) of focus. If you are an ATOD prevention agency and there is an ATOD prevention focused collaborative or coalition in your proposed service area, you must include a MOU to work collaboratively with this group.

If you are an ATOD prevention focused collaborative or coalition and there is an ATOD prevention agency in your proposed service area, you must include a MOU to work collaboratively with this agency. • Be able to describe any training or other capacity building activities needed by any of the involved entities to ensure the success of this project.

Sub awardees must have internal controls in place and use generally accepted accounting principles (GAAP). Successful applicants will show no more than two audit findings in their most recent audit. Successful applicants will have a proven track record of collaboration with community partners to better assure sufficient resources are available to individuals to meet treatment and recovery needs.

## 6. 0 PERFOMANCE OVERSIGHT The DMHDDSAS assumes responsibility for monitoring the performance of the selected applicants and the outcomes of these projects. ## 7.

0 TERM OF CONTRACT, OPTIONS TO EXTEND The performance period for this contract begins on May 1, 2022 and ends September 29, 2022. The budget timeframes will be April 1, 2022 - June 30, 2022, and July 1, 2022 -September 29, 2022. Any extension of funding for the funding period will be determined by the availability of funds and status of goals and outcomes.

The RFA line-item budget shall constitute the total cost to the DMHDDSAS for complete performance in accordance with the requirements and specifications herein, including all applicable expenses such as administrative cost. Contractor shall not invoice for any amounts not specifically allowed for in the line-item budget of this RFA.

The Contractor shall use the Cost Table found in Attachment F: Line-Item Budget to create the Line-Item Budget and Budget Narrative. The Vendor shall not use any other tables or forms, nor modify the contents of any of the shaded cells in the Cost Table. All costs provided in Line-item budget must be firm and fixed for the duration of the contract.

10 ## 9. 0 INVOICING AND REIMBURSEMENT Activities provided under this contract must be separate and distinct from any activities for which the Contractor receives or seeks reimbursement through it capitated or state-funded payments. The contractor shall submit a monthly invoice for based on expenditures by the 15th of the month for services rendered the month prior.

The Contractor’s invoice shall be on the Contractor’s letterhead and shall incorporate an invoice template that the Division shall provide within 10 business days of the Contract’s execution date. Upon award, funds will be allocated to the LME-MCO that has responsibility for the population of the county in which the provider(s) is located.

As stated earlier, applicants must have a current contract or established relationship with the applicable LME-MCO and must include, at minimum, affirmation from the LME-MCO of its agreement and support of the proposal. LME-MCOs will determine the specific billing mechanisms to be utilized for these grant funds and may include both fee-for-service billing, as well as non-UCR funding. ## 10.

0 THE SOLICITATION PROCESS The following is a general description of the process by which agencies or organizations will be selected to complete the goal or objective. 1) Written questions concerning the RFA specifications will be received until the date specified on the cover sheet of this RFA. A summary of all questions and answers will be posted on the RFA web site.

2) Applications will be received from each agency or organization. The original must be signed and dated by an official authorized to bind the agency or organization. 3) All applications must be received by the funding agency not later than the date and time specified on the cover sheet of the RFA.

Faxed applications will not be accepted. 4) At that date and time, the applications from each responding agency and organization will be logged in. 5) At their option, the evaluators may request additional information from any or all Contractors for the purpose of clarification or to amplify the materials presented in any part of the application.

However, agencies and organizations are cautioned that the evaluators are not required to request clarification: therefore, all applications should be complete and reflect the most favorable terms available from the agency or organization.

6) Applications will be evaluated according to completeness, content, experience with similar projects, ability of the agency's or organization's staff, cost, etc. The award of a grant to one agency and organization does not mean that the other applications lacked merit, but that, all facts considered, the selected application was deemed to provide the best service to the State.

7) Agencies and organizations are cautioned that this is a request for applications, and the funding agency reserves the unqualified right to reject any and all 11 applications when such rejections are deemed to be in the best interest of the funding agency. ## 11.

0 GENERAL INFORMATION ON SUBMITTING APPLICATIONS 1) Award or Rejection All qualified applications will be evaluated, and awards made to those agencies or organizations whose capabilities are deemed to be in the best interest of the funding agency. The funding agency reserves the unqualified right to reject any or all offers if determined to be in its best interest. Successful Contractors will be notified by November 30, 2021.

2) Decline to Offer Any agency or organization that receives a copy of the RFA but declines to make an offer is requested to send a written "Decline to Offer" to the funding agency. Failure to respond as requested may subject the agency or organization to removal from consideration of future RFAs.

3) Cost of Application Preparation Any cost incurred by an agency or organization in preparing or submitting an application is the agency's or organizations sole responsibility; the funding agency will not reimburse any agency or organization for any pre-award costs incurred.

4) Elaborate Applications Elaborate applications in the form of brochures or other presentations beyond that necessary to present a complete and effective application are not desired. 5) Oral Explanations The funding agency will not be bound by oral explanations or instructions given at any time during the competitive process or after awarding the grant.

6) Reference to Other Data Only information that is received in response to this RFA will be evaluated; reference to information previously submitted will not suffice. 7) Titles Titles and headings in this RFA and any subsequent RFA are for convenience only and shall have no binding force or effect.

8) Form of Application Each application must be submitted on the form provided by the funding agency, which will become the funding agency's Performance Agreement (contract). 9) Exceptions All applications are subject to the terms and conditions outlined herein. All responses will be controlled by such terms and conditions.

The attachment of other terms and condition by any agency and organization may be grounds for rejection of that agency or organization's application. Funded agencies and organizations specifically agree to the conditions set forth in the Performance Agreement (contract).

10) Advertising In submitting its application, agencies and organizations agree not to use the results therefrom or as part of any news release or commercial advertising without prior written approval of the funding agency.

11) Right to Submitted Material All responses, inquiries, or correspondence relating to or in reference to the RFA, 12 and all other reports, charts, displays, schedules, exhibits, and other documentation submitted by the agency or organization will become the property of the funding agency when received. 12) Competitive Offer Pursuant to the provision of G. S.

143-54, and under penalty of perjury, the signer of any application submitted in response to this RFA thereby certifies that this application has not been arrived at collusively or otherwise in violation of either Federal or North Carolina antitrust laws.

13) Agency and Organization's Representative Each agency or organization shall submit with its application the name, address, and telephone number of the person(s) with authority to bind the agency or organization and answer questions or provide clarification concerning the application.

14) Subcontracting Agencies and organizations may propose to subcontract portions of work provided that their applications clearly indicate the scope of the work to be subcontracted, and to whom. All information required about the prime grantee is also required for each proposed subcontractor.

15) Proprietary Information Trade secrets or similar proprietary data which the agency or organization does not wish disclosed to other than personnel involved in the evaluation will be kept confidential to the extent permitted by NCAC TO1: 05B. 1501 and G. S.

132-1. 3 if identified as follows: Each page shall be identified in boldface at the top and bottom as "CONFIDENTIAL." Any section of the application that is to remain confidential shall also be so marked in boldface on the title page of that section.

16) Participation Encouraged Pursuant to Article 3 and 3C, Chapter 143 of the North Carolina General Statutes and Executive Order No. 77, the funding agency invites and encourages participation in this RFA by businesses owned by minorities, women and the disabled including utilization as subcontractor(s) to perform functions under this Request for Applications.

17) Contract The Division will issue a contract to the recipient of the grant that will include their application. 18) Federal Certifications i) Agencies or organizations receiving Federal funds will be required to execute Federal Certifications regarding Non-discrimination, Drug-Free Workplace, Environmental Tobacco Smoke, Debarment, Lobbying, and Lobbying Activities.

A copy of the Federal Certifications is included in this RFA for your reference (see Appendix A). Federal Certifications should NOT be signed or returned with the application. Please be advised that successful Contractors may be required to have an audit in accordance with G.

S. 143-6. 2 as applicable to the agency or organization’s status.

Also, the contract may include assurances the successful Contractor would be required to execute when signing the contract. Agencies or organizations receiving Federal funds will be required to execute a Consolidated Federal Certification form (as applicable). Private not for profit agency contracts will also include a conflict-of-interest policy statement.

13 ## 12. 0 APPLICATION CONTENT AND INSTRUCTIONS Applications should provide a concise description of the applicant’s capabilities, collaborations, and partnerships. The entire Narrative, which includes the Assessment, Organizational Capacities, Planning Approach, Implementation Plan and Evaluation Plan sections must be no more than ten (10) pages and must be single-spaced in a minimum of Times New Roman 12-point font .

The application must be organized into the following major sections: > ILetter of Transmittal on Agency Letterhead > II Applicant Information I. Letter of Transmittal , signed by the legally authorized signatory and on the applicant’s letterhead, outlining why the applicant chose to apply. Cover letter shall include: 1.

Explanation of why applicant is applying. 2. Evidence of demonstrated need for project in applicant’s catchment area.

3. Explanation of why applicant is suitable candidate, including demonstrated experience with target populations and substances. II.

Applicant Information : Contractor’s name and principal place of business; legal status (whether the contractor is a LME-MCO, community based organization or coalition); the state in which the contractor is incorporated or organized.

The following for each entity must be included: • Agency Executive Director Name • Contact for this Application with Email and Phone Number • Agency Address, Telephone Numbers County/Community Coalition or Collaborative or Prevention Agency • Coalition/Collaborative/Agency Name • Coalition/Collaborative/Agency Director/Coordinator Name 14 • Coalition/Collaborative/Agency Contact for this Application with Email and Phone • Coalition/Collaborative/Agency Address, Telephone Numbers • Area Served by this Coalition/Collaborative/Agency • Collaborative/Agency Website Other Involved Key Stakeholder(s) • Provide relevant information for other key entities that are involved with this project.

III. Program Narrative (maximum 10 pages, excluding attachments) The following Program Narrative is to be completed according to the descriptions provided in each section below: • Describe the nature and extent of prescription drug misuse and abuse in your community. Pay close attention to any identified target populations and trends.

Include other risk and protective factors and the results of any community data, whether formal or informal, that document these health issues in your community. • Provide an overview of the social, cultural and geographic factors that may play a role in encouraging or discouraging prescription drug misuse and abuse in your community. For example, include how, where and when prescription drugs are made available in your community.

This should include, but not be limited to any knowledge you have regarding social access, retail access, informal policies, customs, traditions, norms, lack of existing policy enforcement. • Describe the existing level of readiness in your community to address prescription drug misuse. Submit a “Community Readiness Assessment” (Attachment C).

• Provide a description of the demographic information of target population, as well as the socioeconomic composition of the selected community or county. Organizational Capacities • Describe how the applicant fiscal organization and/or the Organization/Collaborative/Agency is structured and managed. Please include an organizational chart (Attachment D).

• Describe the community’s existing resources and any previous or current efforts to address the identified problems discussed in the Assessment section. Include any developing or established efforts in this description. • Describe the community partners that will participate in this project.

Include a description of the partner’s current area(s) of focus. If you are an ATOD prevention agency and there is an ATOD prevention focused collaborative or coalition in your proposed service area, you must include a MOU to work collaboratively with this group.

If you are an ATOD prevention focused collaborative or coalition and there is an ATOD prevention agency in your proposed service area, you must include a MOU to work collaboratively with this agency. • Describe any training or other capacity building activities needed by any of the involved entities to ensure the success of this project.

15 • Describe the applicants’ experience in developing and implementing prescription drug misuse and abuse prevention best practices, programs and policies, including involvement and partnerships with other community efforts. • Describe how cultural competence and health disparities will be addressed throughout all phases of the planning and implementation processes.

• Describe any previous efforts to implement environmental management strategies to address prescription drug misuse in your target community/area.

• Describe plans to 1) implement environmental approaches, policies and practices, to prevent the onset and reduce the progression of prescription drug use among the target populations; 2) strengthen prevention capacity at the community level; 3) engage key partners; and 4) address health disparities that exist in the target community/area. • Provide a 14-month project timeline for 05/01/2022 through 06/30/2023.

The project timelines need to be split into two. The first timeline needs to be May 1, 2022 - June 30, 2022, and the second timeline July 1, 2022 - June 30, 2023 (Attachment E) that includes specific action steps and responsible parties to reflect the approach related to the SPF process for addressing prescription drug misuse.

At a minimum, please address the following: o Staffing and workforce development/training needs o Conducting additional assessments of community needs and resources. o Analysis of the issue and development of specific goals and actions. o Developing and/or identifying interventions.

o Advocating for change, influencing policy or community norms. o Implementing effective interventions, and • In this section, express your commitment to participating in the SPF-Rx National Cross Site Evaluation plan, which includes a web-based system to track progress and outcomes. • Describe the commitment from necessary key stakeholders to collect local data.

Describe any existing survey instruments that are being used to gather data in the target area. • Describe your experience in evaluating previous prevention initiatives. Describe your ability to plan for sustainability of initiatives beyond the initial funding cycle.

IV. The Applicant shall submit a proposed Budget, utilizing the Line-Item Budget provided in Attachment F. RFA applicants will be selected in part based on clarity and reasonableness of proposed budget.

1. Budget must cover 14 months of the Project. 16 2.

Funding authorized for SPF-Rx activities will not exceed amount proposed in the RFA. V. Letters of Commitment : Grantees should obtain letters of support from all agencies mentioned throughout the grant whether fiduciary agents and/or partners/collaborators.

• Attachment A: Statement of Assurance • Attachment B: SPF-Rx Program Evaluation Requirements • Attachment C: Community Readiness Assessment • Attachment D: Organizational Chart • Attachment E: Project Timeline • Attachment F: Line-Item Budget • Appendix A: Certifications Submit complete Application,